Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

Clinical trial NCT01311232 · COMPLETED

Trial details

NCT number: NCT01311232
Sponsor: Samsung Medical Center
Status: COMPLETED
Study type: OBSERVATIONAL

Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma Patients Treated With Rituximab-CHOP or Rituximab-CVP

Start date: 2010-11-01
Primary completion: 2012-12-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.